Evidence map›Paper›PMID 37945661›Full record

ArticleScientific reports2023

Fractional optimal control strategies for hepatitis B virus infection with cost-effectiveness analysis.

Lemesa Bedjisa Dano, Purnachandra Rao Koya, Temesgen Duressa Keno

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Lemesa Bedjisa Dano *Department of Mathematics, Wollega University, Nekemte, Ethiopia. lemesabjsa@gmail.com.
Purnachandra Rao Koya *Department of Mathematics, Wollega University, Nekemte, Ethiopia.
Temesgen Duressa Keno *Department of Mathematics, Wollega University, Nekemte, Ethiopia.
Wollega University · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis B disease is a communicable disease that is caused by the hepatitis B virus and has become a significant health problem in the world. It is a contagious disease that is transmittable from person to person either horizontally or vertically. This current study is aimed at sensitivity analysis and optimal control strategies for a fractional hepatitis B epidemic model with a saturated incidence rate in the sense of the Caputo order fractional derivative approach. Fundamental properties of the proposed fractional order model are obtained and discussed. A detailed analysis of disease-free equilibrium and endemic equilibrium points is given by applying fractional calculus theory, which is a generalized version of classical calculus. Sensitivity indexes are calculated for the classical order model. Illustrative graphics that show the dependence of the sensitivity index on fractional order derivative for [Formula: see text] are provided. Based on the results of the sensitivity analysis and using Pontryagin's Maximum Principle, optimal control strategies for preventing hepatitis B infection with vaccination and treatment are considered. Fractional Euler's method is used to carry out the numerical simulation for the proposed fractional optimal control system and the obtained results are analyzed. The results of the analysis reveal that hepatitis B disease can be prevented if necessary precautionary is taken or effective vaccination and treatment control measures are applied. The analysis of cost-effectiveness is also conducted and discussed.

Indexed as

CalculiHepatitis BComputer SimulationCost-Effectiveness AnalysisHepatitis B virusHumans

Identifiers

PMID37945661
PMCPMC10636208
OpenAlexW4388540533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.